Stock TTOO T2 BIOSYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
3.65 USD +21.67% Intraday chart for T2 Biosystems, Inc. +32.25% -41.83%
04-29 Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating MT
04-23 Top Premarket Decliners MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating
MT
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
AQ
Top Premarket Decliners
MT
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
AQ
T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc
CI
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Year 2024
CI
Transcript : T2 Biosystems, Inc. - Special Call
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
AQ
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
CI
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
AQ
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
AQ
T2 Biosystems, Inc. Announces Publication of New Study Highlighting Clinical Benefits and Performance of Real-World Use of T2Resistance Panel in Journal of Clinical Microbiology
CI
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
AQ
Transcript : T2 Biosystems, Inc., Q4 2023 Earnings Call, Feb 15, 2024
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
AQ
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
AQ
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
AQ
T2 Biosystems, Inc. Announces Commercial Expansion Through Distributors in Europe and Asia
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TTOO Stock
  4. News T2 Biosystems, Inc.